Topic:

R&D

Latest Headlines

Latest Headlines

Arrowhead's midstage hep B data shows promise for RNA-based 'functional cure'

RNA interference specialist Arrowhead presented new data from an ongoing Phase IIa study of its hepatitis B treatment ARC-520, demonstrating a reduction of the disease's surface antigens in what the company says is a first for RNAi.

Servier gambling up to $1B-plus on Intarcia's PhIII diabetes drug/device

Just a few weeks after claiming success with a pair of late-stage studies of its prolonged dosing approach to diabetes, Boston-based Intarcia has followed up with a billion dollar-plus sized commercialization deal for ex-U.S. and Japan commercial rights with France's Servier.

Nasal spray for migraines under development

Scientists from Nevada's Roseman University of Health Sciences presented their work on a nasal spray formulation of the antipsychotic prochlorperazine for the treatment of migraines at the American Association of Pharmaceutical Scientists annual meeting in San Diego.

Takeda recruits GE to help discover new liver treatments

The growing scourge of liver disease in the developed world has spurred a frenzied race among drug developers to ferret out new therapies, and Takeda, new to the field, has recruited the diagnostics experts at GE Healthcare to shepherd its early R&D efforts.

With fresh infusion of cash in tow, Thync rolls out wearable, noninvasive device to elevate mood

As the med tech industry casts its eye toward wearable, non-invasive devices to elevate mood, startup Thync is developing a smartphone-connected product that boosts users' mood by stimulating nerves in the head.

AbbVie vies for the hep C spotlight on the eve of its Gilead battle

AbbVie is heralding positive new data on its hepatitis C cocktail, touting the treatment's benefit in some tough-to-treat patients as it prepares for a head-to-head competition with market leader Gilead Sciences.

Merck's head-to-head Vytorin trial might be surprisingly flattering

Merck & Co. just disclosed some welcome news for its own investors--and potentially for competitors, too. Not to mention all the market watchers ready for the long IMPROVE-IT trial saga to come to an end.

Device that performs hundreds of tests with a single drop of blood wins Nokia Sensing Xchallenge

The DNA Medicine Institute, developer of a diagnostic device that can perform hundreds of clinical lab tests with a single drop of blood, won the Nokia Sensing Xchallenge for promising medical sensing technologies.

Microsoft 3-D audio system helps the visually impaired navigate more easily

Microsoft engineers have developed a 3-D audio system that can help the visually impaired move about on city streets and within their homes with greater ease using Bluetooth technology.

Open-source atlas of the human proteome goes live

In 2003, a team of scientists and IT engineers set out to create a map of which proteins are found in each part of the body. Now, after committing more than 1,000 man years to the project, the team has released the Human Protein Atlas, an interactive map of the proteome containing 13 million annotated images.